SELLAS Life Sciences Group Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 21.68, 53.09, 122.04, 357.59, 630.29 ], "ebit_estimate": [ -38.98, -30.2, -4, 232.21, 446.75 ], "ebitda_estimate": [ null, null, null, null, null ], "net_income_estimate": [ -37.98, -29.83, -11.76, 203.24, 403.27 ], "per_share_eps_estimate": [ -0.21, -0.15, 0.02, 1.33, 2.55 ], "eps_nri_estimate": [ -0.21, -0.15, -0.03, 1.16, 2.3 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -37.59, -51.75, -56.75, 156.55, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 0, 850.67, 9.59, 5 ], "long_term_growth_rate_mean": 48.82, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": 48.82, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": 45.78, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 23.81, "future_pretax_income_estimate_growth": -29.22, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612" ], "revenue_estimate": [ null, null, 21.68 ], "ebit_estimate": [ -9.08, -9.97, -10.68 ], "ebitda_estimate": [ null, null, null ], "net_income_estimate": [ -9.02, -9.92, -10.63 ], "per_share_eps_estimate": [ -0.05, -0.06, -0.06 ], "eps_nri_estimate": [ -0.05, -0.06, -0.06 ], "dividend_estimate": [ null, null, null ], "book_value_per_share_estimate": [ null, null, null ], "pretax_income_estimate": [ -8.63, -9.65, -10.9 ], "operating_cash_flow_per_share_estimate": [ null, null, null ], "roa_estimate": [ null, null, null ], "roe_estimate": [ null, null, null ], "gross_margin_estimate": [ null, null, null ], "operating_cash_flow_estimate": [ null, null, null ], "pettm_estimate": [ null, null, null ], "long_term_growth_rate_mean": 48.82, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": 48.82, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": 45.78, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 23.81, "future_pretax_income_estimate_growth": -29.22, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }